Literature DB >> 8814073

Comparison of an enzyme-linked immunosorbent assay for antibodies to beta 2-glycoprotein I and a conventional anticardiolipin immunoassay.

R A Roubey1, M A Maldonado, S N Byrd.   

Abstract

Mesh：

Substances：

Year:  1996        PMID： 8814073     DOI： 10.1002/art.1780390922

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  11 in total

1.  Antiphospholipid antibody tests: spreading the net.

Authors:  M L Bertolaccini; S Gomez; J F P Pareja; A Theodoridou; G Sanna; G R V Hughes; M A Khamashta
Journal:  Ann Rheum Dis       Date:  2005-04-07       Impact factor: 19.103

2.  Detection of 'antiphospholipid' antibodies: a single chromogenic assay of thrombin generation sensitively detects lupus anticoagulants, anticardiolipin antibodies, plus antibodies binding beta(2)-glycoprotein I and prothrombin.

Authors:  Y Sheng; J G Hanly; S W Reddel; S Kouts; J Guerin; T Koike; K Ichikawa; A Sturgess; S A Krilis
Journal:  Clin Exp Immunol       Date:  2001-06       Impact factor: 4.330

3.  Localization of the apoptosis-inducing activity of lupus anticoagulant in an annexin V-binding antibody subset.

Authors:  N Nakamura; T Ban; K Yamaji; Y Yoneda; Y Wada
Journal:  J Clin Invest       Date:  1998-05-01       Impact factor: 14.808

4.  Antiphosphatidylserine antibodies in patients with autoimmune diseases and HIV-infected patients: effects of Tween 20 and relationship with antibodies to beta2-glycoprotein I.

Authors:  C González; A Lestón; B García-Berrocal; A Sánchez-Rodriguez; J A Martín-Oterino; I Alberca; M Cordero; R Jorge; J A Navajo; J M González-Buitrago
Journal:  J Clin Lab Anal       Date:  1999       Impact factor: 2.352

5.  Specificity and sensitivity of anti-beta2-glycoprotein I as compared with anticardiolipin antibody and lupus anticoagulant in Thai systemic lupus erythematosus patients with clinical features of antiphospholipid syndrome.

Authors:  Virunya Parkpian; Oravan Verasertniyom; Monchand Vanichapuntu; Kitti Totemchokchyakarn; Kanokrat Nantiruj; Prapaporn Pisitkul; Pantep Angchaisuksiri; Napaporn Archararit; Bupha Rachakom; Katcharin Ayurachai; Suchela Janwityanujit
Journal:  Clin Rheumatol       Date:  2007-03-02       Impact factor: 2.980

6.  Isotype distribution and clinical relevance of anti-beta2-glycoprotein I (beta2-GPI) antibodies: importance of IgA isotype.

Authors:  G Lakos; E Kiss; N Regëczy; P Tarján; P Soltész; M Zeher; E Bodolay; S Szakony; S Sipka; G Szegedi
Journal:  Clin Exp Immunol       Date:  1999-09       Impact factor: 4.330

7.  Anti-cardiolipin and anti-beta2-glycoprotein I antibodies in patients with inflammatory bowel disease.

Authors:  I E Koutroubakis; E Petinaki; E Anagnostopoulou; H Kritikos; I A Mouzas; E A Kouroumalis; O N Manousos
Journal:  Dig Dis Sci       Date:  1998-11       Impact factor: 3.199

8.  The presence of multiple prothrombotic risk factors is associated with a higher risk of thrombosis in individuals with anticardiolipin antibodies.

Authors:  Marie Hudson; Andrée-Laure Herr; Joyce Rauch; Carolyn Neville; Erika Chang; Reda Ibrahim; Chantal Séguin; Jeannine Kassis; Lambert Busque; Paul R Fortin
Journal:  J Rheumatol       Date:  2003-11       Impact factor: 4.666

9.  Antibodies to beta 2-glycoprotein-I: urea resistance, binding specificity, and association with thrombosis.

Authors:  P G Vlachoyiannopoulos; C Petrovas; M Tektonidou; S Krilis; H M Moutsopoulos
Journal:  J Clin Immunol       Date:  1998-11       Impact factor: 8.317

10.  Identification and characterization of a peptide mimetic that may detect a species of disease-associated anticardiolipin antibodies in patients with the antiphospholipid syndrome.

Authors:  Sudha Visvanathan; Jamie K Scott; Kwan-Ki Hwang; Michelle Banares; Jennifer M Grossman; Joan T Merrill; John FitzGerald; Reginald U Chukwuocha; Betty P Tsao; Bevra H Hahn; Pojen P Chen
Journal:  Arthritis Rheum       Date:  2003-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.